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Abstract
© 2017 International Society for Neurochemistry.Organophosphorus agents (OPs) irreversibly
inhibit acetylcholinesterase (AChE) causing a major cholinergic syndrome. The medical counter-
measures  of  OP  poisoning  have  not  evolved  for  the  last  30  years  with  carbamates  for
pretreatment,  pyridinium  oximes-based  AChE  reactivators,  antimuscarinic  drugs  and
neuroprotective benzodiazepines for post-exposure treatment. These drugs ensure protection of
peripheral nervous system and mitigate acute effects of OP lethal doses. However, they have
significant  limitations.  Pyridostigmine  and  oximes  do  not  protect/reactivate  central  AChE.
Oximes  poorly  reactivate  AChE  inhibited  by  phosphoramidates.  In  addition,  current
neuroprotectants do not protect the central nervous system shortly after the onset of seizures
when brain  damage becomes irreversible.  New therapeutic  approaches  for  pre-  and post-
exposure treatments involve detoxification of OP molecules before they reach their molecular
targets by administrating catalytic bioscavengers, among them phosphotriesterases are the
most promising. Novel generation of broad spectrum reactivators are designed for crossing the
blood-brain barrier and reactivate central AChE. This is an article for the special issue XVth
International Symposium on Cholinergic Mechanisms.
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